Search results
Order by most recent / most popular / relevance
Results: 1-10 of 20
PMPRB guidelines and reporting requirements in effect for 2010
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- January 22 2010
The Patented Medicine Prices Review Board (PMPRB) released new Guidelines in 2009, including the new pricing tests the Board will apply for patented medicines
New regulations respecting benefits and promotional allowances in Québec
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- November 16 2007
The Government of Québec has introduced new regulations under the Act Respecting Prescription Drug Insurance governing the rebates and other benefits offered by drug manufacturers to pharmacists
In a new decision, the PMPRB identifies "exceptional" circumstances when a patentee may increase prices in excess of its guidelines
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- March 6 2008
In a decision made public on March 4, 2008, the Patented Medicine Prices Review Board (PMPRB) has found that a price increase greater than the annual increase in the CPI is not excessive
Court overturns PMPRB's decisions in respect of the medicine copaxone
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- November 18 2009
On November 12, 2009, Justice Hughes of the Federal Court allowed two judicial review applications of Teva Neuroscience G.P.-S.E.N.C. in respect of two decisions made by the Patented Medicine Prices Review Board
Celgene Corporation v Canada (AG) - Supreme Court of Canada grants leave to appeal
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- May 21 2010
The Supreme Court of Canada has granted Celgene Corporation's application for leave to appeal the decision of a majority of the Federal Court of Appeal regarding the jurisdiction of the Patented Medicine Prices Review Board
Eli Lilly Canada and PMPRB reach agreement on the price of Forteo
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- July 10 2007
On July 6, 2007, the PMPRB announced that it has approved a Voluntary Compliance Undertaking by Eli Lilly Canada with respect to Forteo
PMPRB issues Notice of Hearing - Apotex Inc
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- April 21 2008
The Patented Medicine Prices Review Board (PMPRB) has issued a Notice of Hearing into certain allegations against Apotex Inc
PMPRB departs from its guidelines in determining price in recent decision
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- April 21 2008
In a significant decision dated April 10, 2008, a Hearing Panel of the Patented Medicine Prices Review Board (PMPRB) has ruled that it is not appropriate to apply the PMPRB's Excessive Price Guidelines to assess the pricing of once-daily drugs used to treat attention deficit hyperactivity disorder (ADHD
PMPRB releases 2006 Annual Report
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- August 15 2007
The Patented Medicine Prices Review Board (PMPRB) tabled its 2006 Annual Report before Parliament on July 18
A new discussion paper from the PMPRB
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- February 7 2008
The Patented Medicine Prices Review Board (PMPRB) has issued a discussion paper containing some specific proposals and options related to: its review of the Excessive Price Guidelines; and the controversy surrounding the implications of the Federal Court of Canada decision in the LEO Pharma case on the reporting of discounts and rebates
Current Search
- Workarea - Healthcare
- Workarea - Intellectual Property
- Workarea - Competition
- Firm Name - Gowling Lafleur Henderson LLP
- Jurisdiction - Canada